Dublin, Jan. 03, 2017 -- Research and Markets has announced the addition of the "Acne Vulgaris Forecast in 15 Major Markets 2016-2026" report to their offering.
This report provides the current prevalent population for Acne Vulgaris across 15 Major Markets (USA, Canada, France, Germany, Russia, Italy, Spain, UK, Turkey, Poland, Australia, Japan, China, Brazil and India) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team, several of the main symptoms and co-morbidities of Acne Vulgaris have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main symptoms and co-morbidities for Acne Vulgaris include:
- Underlying hormone imbalance
- Puberty
- Family history
- Skin scarring
Key Topics Covered:
1. Introduction
2. Cause of the Disease
3. Risk Factors & Prevention
4. Diagnosis of the Disease
5. Variation by Geography/Ethnicity
6. Disease Prognosis & Clinical Course
7. Key comorbid conditions/Features associated with the disease
8. Methodology for quantification of patient numbers
9. Top-line prevalence for Acne Vulgaris
10. Features of Acne Vulgaris patients
11. Predominant Features of Acne Vulgaris
12. Comorbid Conditions and Features of Acne Vulgaris
13. Scarring in Patients with Acne Vulgaris
14. Location of Acne
15. Patient-Based Offering
16. Online Pricing Data and Platforms
17. References
18. Appendix
For more information about this report visit http://www.researchandmarkets.com/research/g2tng6/acne_vulgaris
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Dermatology


Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Unilever and Magnum Face Defamation Lawsuit Over Ben & Jerry's Board Chair Dismissal
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Brown-Forman and Pernod Ricard in Merger Talks to Create World's Largest Spirits Giant
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
Apple Turns 50: From Garage Startup to AI Crossroads
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Bank of America's $72.5M Epstein Settlement: What You Need to Know
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations 



